An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder

NCT01038128 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Bulimia Nervosa
Body Dysmorphic Disorder

Interventions

DRUG: Memantine

Sponsor

Mclean Hospital